EDGAR Filing Documents for 0001437749-17-006686

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001437749-17-006686

Filing Date

2017-04-18

Accepted

2017-04-17 21:48:27

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	atrn20161231_10k.htm	10-K	1750936
2	EXHIBIT 10.16	ex10-16.htm	EX-10.16	50748
3	EXHIBIT 14.1	ex14-1.htm	EX-14.1	75019
4	EXHIBIT 14.2	ex14-2.htm	EX-14.2	45989
5	EXHIBIT 14.3	ex14-3.htm	EX-14.3	5805
6	EXHIBIT 23.1	ex23-1.htm	EX-23.1	3518
7	EXHIBIT 31.2	ex31-2.htm	EX-31.2	23971
8	EXHIBIT 32.1	ex32-1.htm	EX-32.1	13063
9	EXHIBIT 99.1	ex99-1.htm	EX-99.1	17849
	Complete submission text file	0001437749-17-006686.txt		6349507

Data Files

Seq	Description	Document	Type	Size
10	EXHIBIT 101.INS	ptix-20161231.xml	EX-101.INS	959021
11	EXHIBIT 101.SCH	ptix-20161231.xsd	EX-101.SCH	58680
12	EXHIBIT 101.CAL	ptix-20161231_cal.xml	EX-101.CAL	24367
13	EXHIBIT 101.DEF	ptix-20161231_def.xml	EX-101.DEF	480422
14	EXHIBIT 101.LAB	ptix-20161231_lab.xml	EX-101.LAB	356147
15	EXHIBIT 101.PRE	ptix-20161231_pre.xml	EX-101.PRE	486581

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010

Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200

Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)